HTG Molecular Diagnostics, Inc. Operating Lease Right-of-Use Assets
HTG Molecular Diagnostics, Inc. had Operating Lease Right-of-Use Assets of $892.68 thousand as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-05-11
- 2023-03-31: Operating Lease, Right-of-Use Asset $892.68K.
- 2022-12-31: Operating Lease, Right-of-Use Asset $1.01M.
- 2022-09-30: Operating Lease, Right-of-Use Asset $1.04M.
- 2022-06-30: Operating Lease, Right-of-Use Asset $1.14M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-03-31 | $892.68K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.01M 10-Q · filed 2023-05-11 |
| 2022-09-30 | $1.04M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.14M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $1.25M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.35M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.44M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $246.32K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $349.07K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.01M 10-K · filed 2022-03-29 |
| 2020-09-30 | $746.18K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $905.46K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.04M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.21M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.37M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.39M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $621.43K 10-Q · filed 2019-05-09 |